This inventor holds 2 USPTO granted patents. Top assignees: Biomolecular Research Institute Ltd., Commonwealth Scientific and Industrial Research Organisation, Macfarlane Burnet Centre for Medical Research Ltd.- Fairfield Hospital. Active years: 1999-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5 
1 out of 1,355 
1 out of 1 Years Active: 1999-2001
Title: The Innovative Contributions of Ian MacReadie
Introduction
Ian MacReadie is a notable inventor based in Melbourne, Australia, who has made significant contributions to the field of therapeutic compounds. With two patents to his name, he has focused his research on biologically-active peptides related to the human immunodeficiency virus (HIV) and their potential applications in pharmaceuticals.
Latest Patents
MacReadie's most recent patents center around innovative therapeutic compounds. These inventions involve a biologically-active peptide fragment of the Nef protein of HIV. The patents cover various pharmaceutical compositions that comprise these peptides and their biologically-active analogues. Additionally, they include antagonists of the peptides and the pharmaceutical compositions that utilize these antagonists, along with therapeutic and screening methods that apply the compounds and compositions developed in his research.
Career Highlights
Throughout his career, MacReadie has been associated with reputable research institutions such as the Biomolecular Research Institute Ltd. and the Macfarlane Burnet Centre for Medical Research located at Fairfield Hospital. His work in these institutions has propelled advancements in medical research, particularly concerning HIV and related therapeutic applications.
Collaborations
Ian has collaborated with esteemed colleagues in his field, including Ahmed Abdullah Azad and Cyril C. Curtain. These partnerships have enriched his research and have contributed to the development of innovative solutions in biochemical pharmacology.
Conclusion
Ian MacReadie's inventive efforts and dedication to research highlight the importance of innovation in the medical field. His patents not only represent a significant leap forward in therapeutic compounds but also reflect the collaborative spirit within the research community that drives progress in healthcare advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile